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Abstract
Background: Campylobacteriosis is one of the most commonly identified causes of bacterial
diarrheal disease and a common cause of gastroenteritis in travellers from developed nations.
Despite the widespread occurrence, there is little information on Campylobacter mortality.
Methods: Mortality among a cohort of Campylobacter cases were compared with the general
population 0–1, 1–3, 3–12 and more than 12 month after the onset of the illness. The cases were
sub-grouped according to if they had been infected domestically or abroad.
Results: The standardized mortality ratio for cases infected domestically was 2.9 (95% CI: 1.9–4.0)
within the first month following the illness. The risk then gradually diminished and approached 1.0
after one year or more have passed since the illness. This initial excess risk was not attributable to
any particular age group (such as the oldest).
In contrast, for those infected abroad, a lower standardized mortality ratio 0.3 (95% CI: 0.04–0.8)
was shown for the first month after diagnosis compared to what would be expected in the general
population.
Conclusion: Infection with Campylobacter is associated with an increased short-term risk of death
among those who were infected domestically. On the contrary, for those infected abroad a lower
than expected risk of death was evident. We suggest that the explanation behind this is a "healthy
traveler effect" among imported cases, and effects of a more frail than average population among
domestic cases.
Background
Campylobacteriosis is a zoonotic disease observed in
most parts of the world. The disease is caused by Campylo-
bacter jejuni, or less commonly Campylobacter coli. It is esti-
mated to cause 5–14% of diarrhea, worldwide [1], and
causes a great amount of hospital bed days in all coun-
tries. In the United States, campylobacteriosis account for
approximately 17% of hospitalizations due to food borne
infections [2], and in England and Wales Campylobacter is
by far the most important food-borne pathogen when it
comes to GP consultations, hospital admissions and hos-
pital bed days [3]. In Sweden, campylobacteriosis is the
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most common bacterial food-borne disease. Since 1997,
between 6,900 and 8,600 annual cases (78–96 per
100,000) have been reported to the Swedish Institute for
Infectious Disease Control (SMI), of which approximately
55% were imported [4].
Apart from diarrhea, many patients experience abdominal
pain, often accompanied by fever, malaise and headache.
The diarrhea can range from mild to profuse, causing
dehydration. There are also some known although rare
complications to Campylobacter infection; Guillain-Barré
syndrome is thought to occur after 1 in 1,000 cases of C.
jejuni infection [5,6]. This involves autoantibodies against
distinct surface polysaccharides that are similar to host
ganglioside structures [7]. Reactive arthritis and Reiter's
syndrome (asymmetric arthritis, urethritis and oph-
thalmitis) are other extra-intestinal manifestations caused
by Campylobacter, which affects approximately 1% of cases
[8].
Although Campylobacter infection is both very common
and can sometimes result in severe complications, less is
known about the mortality attributable to Campylobacter
infection. In this study we therefore via registry linkage
estimated the mortality in a cohort of Campylobacter cases
in Sweden. The primary objective was to investigate if
cases diagnosed with Campylobacter have a mortality rate
from all causes that differs from the general population. If
so, the second objective was to see if this all cause mortal-
ity rate among campylobacterosis cases mirrors Campylo-
bacter related mortality rates. We would in this case expect
any elevated mortality rate in the Campylobacter cohort
to be highest close to infection and then gradually dimin-
ish with time and approach the general mortality rate in
the population.
Methods
Sweden has a dual reporting system for notifiable infec-
tious diseases. This means that both the doctor having
seen the patient and the laboratory having isolated the
pathogen are required to file a report to the SMI. Using a
unique personal identification number, issued to all
Swedish residents, and used in all contacts with the health
care, reports from the two sources are merged into case
files.
For this study, we identified all persons reported with
campylobacteriosis to the SMI between January 1, 1997
and December 31, 2003. For each case we extracted date
of birth, sex, country of infection, date of disease onset,
date of diagnosis and reporting date from the database. If
the date for disease onset or date of diagnosis was missing
we used the median time from patients who have all three
dates to back-calculate a date for disease onset. These cases
were then via the personal identification number linked
to a database that contain information from the National
Tax Board on every deceased person in Sweden and their
date of death.
We then calculated follow-up time per age group, from
the date of disease onset until either an event took place
(death) or until November 1, 2004. The following time
strata were used; 0–1 month, 1–3 months, 3–12 months
and more than 12 months after the onset of campylobac-
teriosis. The first time strata was constructed to be long
enough so that acute effects of even prolonged illness was
not missed. The other cut-off was chosen so that effects
between strata could be evident (for example a declining
risk with time) and that each time strata contained a suf-
ficient amount of person-time for robust estimations.
From Statistics Sweden we obtained sex- and age-specific
death rates, which were used to obtain the expected
number of deaths. Standardized mortality ratios (SMRs)
were calculated by dividing the observed number of
deaths in our cohort with the expected number of deaths.
If the result was >1.0, then the mortality in the Campylo-
bacter cohort was higher than in the general population,
and conversely, if the ratio was <1.0 then the mortality
among our cases was lower than in the general popula-
tion. The SMR is a weighted average of all age groups in
the  Campylobacter  cohort. This indirect standardization
was done with 5-year age strata (e.g. 0–4, 5–9, etc.) but is
presented here either as SMR, or grouped into broader cat-
egories e.g. 0–14 years, 14–64 years and +65 years.
With the assumption that those who had acquired their
infection abroad and those who had contracted it at home
were two fundamentally different groups – the former
probably healthier than the latter ("healthy traveler
effect") – we divided our Campylobacter cohort into two
groups, imported and domestic cases [9].
Exact confidence intervals and tests were calculated
assuming that the number of deaths in each stratum was
Poisson distributed. Within each time stratum the
observed SMRs for each age group were compared using
an exact test. The observed number of cases was assumed
to be multinomially distributed over the age classes with
probabilities proportional to the expected values. All cal-
culations were performed using SAS statistical software, V.
8.2.
Results
During the study period 1997–2003, 48,025 unique indi-
viduals were notified with Campylobacter  infection, of
whom 16,710 were infected in Sweden, and 28,930 were
infected abroad. For the remaining 2,385 cases either the
personal identification number was incomplete, or the
country of infection was unknown.BMC Infectious Diseases 2005, 5:70 http://www.biomedcentral.com/1471-2334/5/70
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For cases reported with Campylobacter and infected in Swe-
den, the SMR was higher compared to the general Swedish
population (Table 1). The risk was highest within the first
month after onset of disease (SMR 2.9; 95% CI 1.9–4.0).
After that time period the risks gradually decreased and
after one year had passed after the debut of illness, the risk
was the same as for the general population (SMR 1.0; 95%
CI 0.9–1.1)
To see if this early excess mortality risk was attributable to
any particular age group within the group of domestically
infected individuals, we divided the cohort into three age
groups (0–14 years, 15–64 years and 65 years and above).
Table 2 shows the mortality ratios for these separate age
groups. No significant differences between the groups
were found at any of the time periods following the illness
(the lowest p-value is 0.20). Persons infected with Campy-
lobacter abroad, had lower SMR compared to the general
population (Table 1). We observed less number of deaths
than expected in every time stratum after the debut of ill-
ness. Within the first month after the disease SMR was 0.3
(95% CI 0.04–0.8), and a significantly lower risk com-
pared to the reference population was evident for every
time period except for the second time stratum (1–3
months after infection) where the SMR was 0.7 (95% CI:
0.4–1.3).
Discussion
The SMR was almost three times higher for persons
infected with Campylobacter  in Sweden within the first
months after disease onset. These risks diminished with
time, and after a year or more have passed the SMR almost
equaled that for the general population. For the imported
cases of Campylobacter we observed lower SMRs through-
out every time point in the study period.
Case fatality rate (CFR) is widely used and perhaps more
intuitive than standardized mortality ratio when disease
specific mortality is estimated. Up until November 1,
2004, 563 of the cases infected in Sweden, and 222 of the
cases infected abroad had died. The CFR within 30 days
was 0.19% (95% CI 0.13–0.27%) for those infected in
Sweden, and 0.008% (95% CI 0.0008–0.03%) for those
infected abroad. However, we do not favour the use of
CFR because information on competing causes of mortal-
ity is missing, along with age effects.
The different SMRs depending on whether a case was
infected at home or abroad must be analyzed in a context
of how a case is diagnosed and reported. For gastrointesti-
nal diseases there are problems with under-reporting and
biases regarding which cases that eventually turns up in
the national routine surveillance.
The problems with under-reporting affect every step in the
chain: an ill person must seek health care, the doctor
needs to take a stool sample, the laboratory must be capa-
ble of accurately detecting the pathogen, and if the labo-
ratory find the pathogen the doctor needs to send in a
notification. It is perhaps in the first of these steps that
national surveillance misses most of the cases. Studies in
both United Kingdom and United States have tried to
measure the proportion reported to national surveillance
from those who have symptoms of infectious intestinal
disease in the population. For an agent like Campylobacter
that typically causes non-bloody diarrhea a multiplier in
the range of 7.6–38 has been estimated [10,11].
All persons who get infected with Campylobacter do not
have the same chance of becoming notified as a Campylo-
bacter case. There are three different groups that are more
likely than others to be reported [12]. Firstly, people who
have a severe disease or profound symptoms are more
likely to see a doctor, compared to others. Secondly, per-
sons with a history of recent travel prior to the onset of
symptoms are also more likely to seek health care and
become diagnosed and reported. Thirdly, persons with
pre-existing illnesses of certain magnitude may be over-
represented in the national surveillance statistics.
These biases in disease reporting will have an impact on
our findings and can help us in the interpretation of the
Table 1: Standardized mortality ratios (SMR) during the period 1997–2003 among 45,640 Swedish reported cases of 
campylobacteriosis, infected in Sweden (n = 16,710) and abroad (n = 28,930)
Infected in Sweden Infected abroad
Time after infection (months) Obs* (n = 563) Exp* SMR* (95% CI*) Obs (n = 222) Exp SMR (95% CI)
0–1 30 10.4 2.9 (1.9–4.0) 2 6.8 0.3 (0.04–0.8)
1–3 31 20.7 1.5 (1.0–2.1) 10 13.7 0.7 (0.4–1.3)
3–12 123 93.9 1.3 (1.1–1.6) 28 63.3 0.4 (0.3–0.6)
>12 379 388.6 1.0 (0.9–1.1) 182 330.6 0.6 (0.5–0.6)
* Obs, observed number of deaths; Exp, expected number of deaths; SMR, standardized mortality ratio; CI, confidence intervalBMC Infectious Diseases 2005, 5:70 http://www.biomedcentral.com/1471-2334/5/70
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results. The general under-reporting will affect milder
cases in particular. Therefore, the persons in our cohort
infected in Sweden were most likely the more severe cases
in the population. On the other hand, travellers who
develop symptoms of gastro-enteritis are more likely on
the average to have a physical exam when they have
returned home and they do not necessary need to have a
severe disease. The finding of a standardized mortality
ratio equal to 1.0 after one year had passed after the infec-
tion suggest that the mortality of this cohort infected
domestically is comparable to the standard Swedish pop-
ulation after one year. This does not necessarily imply that
the cohort is comparable to the Swedish population also
at the earlier time points. The risk profile may have
changed due to frailty. The statistical term frailty implies
that all individuals do not have the same risk profile and
frailer individuals may succumb earlier and therefore the
risk profile of a cohort changes over time [13].
It is difficult to find information on Campylobacter associ-
ated mortality. Some have estimated the case fatality rate
to be in range of 1–3/10000 cases [14]. Others that have
used an approach more like ours found that 1.2% (16180
cases and 190 deaths) where deceased within one year
from diagnosis [15]. Unfortunately, no study has com-
pared mortality risks among travellers and non-travellers
for campylobacteriosis.
Our findings suggest that the individuals reported into the
surveillance system are a highly selected. Individuals with
a domestically contacted infection may have a different,
more severe risk profile, compared to individuals in the
cohort with an imported infection. The reason for these
differences is not characteristics of the infection itself but
reflects differences in how these individuals are selected
into the surveillance system. Any registry-based estima-
tion of mortality among cases of campylobacteriosis must
therefore take this into account and stratify cases accord-
ing to the place of infection.
Conclusion
In conclusion, we found in our study cohort two groups
of persons with opposite mortality risks within the first
month after a Campylobacter infection. Persons who had
acquired their infection in Sweden had almost a three
times higher than expected risk to die. The larger group of
persons, having picked up their infection abroad, had, on
the contrary, a lower than expected risk to die, likely due
to a "healthy traveler effect". In estimations of mortality or
burden of disease regarding campylobacteriosis one
should be aware that travellers differ in many characteris-
tics compared to non-travellers. In countries where
imported cases are in majority, these two groups must be
handled separately to avoid any misinterpretation of the
true burden of disease.
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